About Day Zero Diagnostics
Day Zero Diagnostics is a company based in Boston (United States) founded in 2016.. Day Zero Diagnostics has raised $48.6 million across 10 funding rounds from investors including NIH, BD and CARB-X. The company has 48 employees as of December 31, 2024. Day Zero Diagnostics offers products and services including epiXact® Service, Whole Genome Sequencing Diagnostics, and Computational Diagnostic Algorithms. Day Zero Diagnostics operates in a competitive market with competitors including Cepheid, Prenetics, Karius, OpGen and Clear Labs, among others.
- Headquarter Boston, United States
- Employees 48 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Day Zero Diagnostics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.6 M (USD)
in 10 rounds
-
Latest Funding Round
$16 M (USD), Series B
Sep 20, 2023
-
Investors
NIH
& 10 more
-
Employee Count
48
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Day Zero Diagnostics
Day Zero Diagnostics offers a comprehensive portfolio of products and services, including epiXact® Service, Whole Genome Sequencing Diagnostics, and Computational Diagnostic Algorithms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides rapid genome sequencing for pathogen relatedness in hospitals.
Offers quick ID and AMR profiling for infectious diseases treatment.
Delivers algorithms for analyzing genomic data in disease diagnostics.
Unlock access to complete
Funding Insights of Day Zero Diagnostics
Day Zero Diagnostics has successfully raised a total of $48.6M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $16.0M
-
First Round
First Round
(23 May 2017)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series B - Day Zero Diagnostics | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - Day Zero Diagnostics | Valuation |
investors |
|
| Oct, 2022 | Amount | Grant - Day Zero Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Day Zero Diagnostics
Day Zero Diagnostics has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, BD and CARB-X. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A life sciences venture fund is operated with global reach.
|
Founded Year | Domain | Location | |
|
Tech & Life-Sciences focused VC Firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early stage healthcare startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Day Zero Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Day Zero Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Day Zero Diagnostics Comparisons
Competitors of Day Zero Diagnostics
Day Zero Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Prenetics, Karius, OpGen and Clear Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Day Zero Diagnostics
Frequently Asked Questions about Day Zero Diagnostics
When was Day Zero Diagnostics founded?
Day Zero Diagnostics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Day Zero Diagnostics located?
Day Zero Diagnostics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Day Zero Diagnostics a funded company?
Day Zero Diagnostics is a funded company, having raised a total of $48.6M across 10 funding rounds to date. The company's 1st funding round was a Grant of $8.2M, raised on May 23, 2017.
How many employees does Day Zero Diagnostics have?
As of Dec 31, 2024, the latest employee count at Day Zero Diagnostics is 48.
What does Day Zero Diagnostics do?
Day Zero Diagnostics was founded in 2016 in Boston, United States, within the health technology sector. Diagnostic solutions based on machine learning and genomics are provided for infectious diseases. Whole-genome sequencing is utilized in assays such as Blood2Bac and BacDetect to identify infecting bacterial species and drug resistance. Operations focus on advancing rapid diagnostics for clinical applications.
Who are the top competitors of Day Zero Diagnostics?
Day Zero Diagnostics's top competitors include Cepheid, Prenetics and Clear Labs.
What products or services does Day Zero Diagnostics offer?
Day Zero Diagnostics offers epiXact® Service, Whole Genome Sequencing Diagnostics, and Computational Diagnostic Algorithms.
Who are Day Zero Diagnostics's investors?
Day Zero Diagnostics has 11 investors. Key investors include NIH, BD, CARB-X, Sands Capital, and Panacea Venture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.